Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Alzheimer's disease risk SNPs show no strong effect on miRNA expression in human lymphoblastoid cell lines

Inken Wohlers, Colin Schulz, Fabian Kilpert, Lars Bertram*

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

The role of microRNAs (miRNAs) in the pathogenesis of Alzheimer's disease (AD) is currently extensively investigated. In this study, we assessed the potential impact of AD genetic risk variants on miRNA expression by performing large-scale bioinformatic data integration. Our analysis was based on genetic variants from 3 AD genome-wide association studies (GWASs). Association with miRNA expression was tested by expression quantitative trait locus analysis using next-generation miRNA sequencing data generated in lymphoblastoid cell lines. Although, overall, we did not identify a strong effect of AD GWAS variants on miRNA expression in this cell type, we highlight 2 notable outliers, that is, miR-29c-5p and miR-6840-5p. MiR-29c-5p was recently reported to be involved in the regulation of BACE1 and SORL1 expression. In conclusion, despite 2 exceptions, our large-scale assessment provides only limited support for the hypothesis that AD GWAS variants act as miRNA expression quantitative trait loci.

OriginalspracheEnglisch
ZeitschriftNeurobiology of Aging
Jahrgang86
Seiten (von - bis)202.e1-202.e3
ISSN0197-4580
DOIs
PublikationsstatusVeröffentlicht - 02.2020

Fördermittel

Computational support was provided by the OMICS compute cluster at the University of Lübeck. The authors thank Dr. Chun for help with JLIM, Dr. Gusev for help with TWAS/FUSION, and Dr. Lill for advice on implementing the ADmiReQTL workflow. Funding was provided by Peter und Traudl Engelhorn Foundation (to IW), by the European Medical Information Framework–Alzheimer’s Disease (EMIF-AD) [grant number 115372 ] (to LB), and by the Deutsche Forschungsgemeinschaft (DFG) [grant number BE2287/8 - 391523883 ] (to LB). Appendix A

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 10 – Weniger Ungleichheiten
    SDG 10 – Weniger Ungleichheiten

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Alzheimer's disease risk SNPs show no strong effect on miRNA expression in human lymphoblastoid cell lines“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren